E

Envista Holdings Corp
NYSE:NVST

Watchlist Manager
Envista Holdings Corp
NYSE:NVST
Watchlist
Price: 19.31 USD 1.9%
Market Cap: 3.3B USD
Have any thoughts about
Envista Holdings Corp?
Write Note

Envista Holdings Corp
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Envista Holdings Corp
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
E
Envista Holdings Corp
NYSE:NVST
Current Portion of Long-Term Debt
$115.3m
CAGR 3-Years
-49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Current Portion of Long-Term Debt
$2.2B
CAGR 3-Years
63%
CAGR 5-Years
11%
CAGR 10-Years
27%
Boston Scientific Corp
NYSE:BSX
Current Portion of Long-Term Debt
$1.7B
CAGR 3-Years
85%
CAGR 5-Years
5%
CAGR 10-Years
88%
Stryker Corp
NYSE:SYK
Current Portion of Long-Term Debt
$2.2B
CAGR 3-Years
361%
CAGR 5-Years
33%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Current Portion of Long-Term Debt
$2.2B
CAGR 3-Years
42%
CAGR 5-Years
11%
CAGR 10-Years
26%
Intuitive Surgical Inc
NASDAQ:ISRG
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Envista Holdings Corp
Glance View

Market Cap
3.3B USD
Industry
Health Care

Envista Holdings Corp., a prominent player in the dental industry, spins a captivating narrative of innovation and expertise. Emerging from a legacy rooted in the exceptional engineering standards of Danaher Corporation, Envista was formed to focus sharply on dental products and solutions. Its operational structure is divided into three main segments: Specialty Products & Technologies, Orthodontic Products, and Equipment & Consumables. With a strategic emphasis on orthodontics and endodontics, the company engineers advanced technological solutions such as clear aligners, imaging software, and digital treatment planning tools. This specialization is key to its operations, allowing Envista to cater to dental practitioners' diverse needs with products that boost the efficiency and precision of dental treatments. Revenue generation for Envista hinges upon its broad portfolio of trusted brands, including KaVo Kerr, Nobel Biocare, and Ormco, which are synonymous with quality in the dental field. Through these brands, Envista not only manufactures and sells premium dental equipment and supplies, but also provides comprehensive services from maintenance and repair to educational support. The company utilizes a robust distribution network and partners with dental service organizations globally, ensuring its products reach a wide audience. Furthermore, Envista’s commitment to research and development fuels its profitability by continually offering state-of-the-art solutions that meet the evolving demands of the dental industry. This relentless focus on innovation and customer-centric approaches underpin its financial performance, positioning Envista as a formidable force in its market.

NVST Intrinsic Value
25.34 USD
Undervaluation 24%
Intrinsic Value
Price
E

See Also

What is Envista Holdings Corp's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
115.3m USD

Based on the financial report for Dec 31, 2023, Envista Holdings Corp's Current Portion of Long-Term Debt amounts to 115.3m USD.

What is Envista Holdings Corp's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
-49%

Over the last year, the Current Portion of Long-Term Debt growth was -77%. The average annual Current Portion of Long-Term Debt growth rates for Envista Holdings Corp have been -49% over the past three years .

Back to Top